Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated, Neuronavigated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

NCT07428460 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.

NCT NCT07428460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07428460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated, Neuronavigated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
Lead sponsor
Douglas Mental Health University Institute
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
May 31, 2028
Enrollment
75 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia and predominant negative symptoms